What We Do


Commitment to Innovation

Our venture is developing a therapeutic targeting elevated endothelin-1 levels that may be used in diabetes, cardiovascular and neurodegenerative diseases, different cancers as also pregnancy disorders.


Drug Development

We believe we have discovered a potent therapy for diabetes,  both type 1 and type 2, as well as a potential treatment for cardiovascular and other disorders.